The global high-throughput screening market is witnessing considerable
growth due to increasing geriatric population, increasing healthcare
expenditure, increasing research and development activities, launch of
technologically advanced products that are miniaturized and automated and
growing popularity of high-throughput screening for drug discovery.
Moreover, high adoption of high-throughput screening models in
pharmaceutical and biotechnology companies across the globe is supporting the
growth of the market. Based on technology, 2D cell culture segment is expected
to grow at the fastest rate during the forecast period owing to its low cost
and ease of use.
Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/high-throughput-screening-market/report-sample
The rapid growth in emerging economies and growing research and
development activities on stem cells and toxicology is expected to create
opportunities for the manufacturers of high-throughput screening products.
However, high cost of high-throughput screening, lack of trained professionals
and complexity in assay development are the key factors hampering the growth of
the global market.
Geographically, North America has been the largest market for
high-throughput screening, owing to its increased awareness, increasing
government funding, established healthcare industry, and easy accessibility to
advanced technologies due to the awareness in the region. The U.S. contributed
largest revenue to the North American as well as global high-throughput
screening market.
Make Enquiry Before Buying the Report@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=high-throughput-screening-market
The key players operating in the global market are Agilent Technologies,
Inc, Danaher Corporation, Thermo Fisher Scientific Inc., Merck Millipore,
Bio-Rad Laboratories, Inc., Hamilton Company and Aurora Biomed, Inc.
No comments:
Post a Comment